Nature published a cautionary tale about RAG in clinical practice.
The Story
The article highlights concerns around AI ‘truthfulness’.
Why It Matters
This isn't about shiny new tools. For CROs and small biotech, the Nature piece on RAG’s 'truthfulness' in clinical settings is a direct warning. Relying on AI for critical decisions without robust validation means risking patient safety and regulatory compliance, particularly with the EU AI Act approaching. Your data integrity and output reliability are paramount, not just speed.
What To Do About It
Before deploying any AI for clinical insights, audit your RAG implementation. What are your validation protocols for AI-generated medical information? I'd check how you're securing data sovereignty and ensuring your AI outputs are verifiable, not just plausible.
Sources
Related Signals
Mankind Pharma partnered with Denovo Sciences for AI-led drug discovery.
2 Jul 2026
Galux is pushing AI protein design, aiming for bigger global pharma deals by BIO USA 2026. This indicates a clear industry focus on advanced AI applications for drug discovery and development.
29 Jun 2026
Logicboots introduced Coeur.AI at VivaTech Paris 2026. This launch is part of Logicboots' strategy to expand its global footprint through startup accelerators.
28 Jun 2026